BRICS stress the need to create an early warning system for epidemic risk – Eurasia Review

In their final declaration, the leaders of the BRICS group (Brazil, Russia, India, China and South Africa) at the end of their 14th summit organized by China, underlined their commitment to the need to create a complex system of early warning for epidemic risks within the group, and underlined that Member States must be better prepared for future health emergencies.

The group also advocated for “equitable distribution of vaccines” and called on international agencies and charities to buy vaccines and boosters “from manufacturers in developing countries, including in Africa, to ensure that the capacities products under development are retained”.

Russia has pleaded for closer collaboration among members, but China appears to be the quickest to take action on health-related issues. Under Russia’s leadership, he first proposed cooperation on combating infectious diseases as a priority for the BRICS. The joint outcome statement from the 2015 BRICS summit in Ufa, Russia, contains instructions for leaders to work cohesively on managing the risk of disease outbreaks.

“We are concerned about the growth and diversification of global threats posed by communicable and non-communicable diseases. This has a negative impact on economic and social development, especially in developing and least developed countries,” the 2015 BRICS statement said.

Within the group, China and India stood ready to step up information and experience sharing with BRICS countries and conduct joint research and development of medicines and vaccines with respect for sovereignty and rights. national conditions of the other.

During South Africa’s rotating presidency, he strongly re-proposed the establishment of a large-scale research and development coordination center and planned to be located in Johannesburg, South Africa.

Nevertheless, there were no practical achievements in this direction. Then Covid-19 started in December 2019 and was declared a pandemic the following year by the World Health Organization (WHO). When China assumed the leadership of the BRICS, beginning in January 2022, experts and research analysts have since shown deep interest and further discussed opportunities for multilateral cooperation, existing challenges, and identification of various priorities, strengths and weaknesses of the BRICS.

With notable efforts, the BRICS have consistently pushed for various health initiatives, especially vaccines, to halt the coronavirus pandemic that has upended the global economy. There are Chinese and Russian vaccines, both reported to be effective and safe, and are now gearing up to ramp up large-scale production.

March 22 marked the launch of the BRICS Vaccine Research and Development Center, involving the heads of relevant agencies from the five countries. The initiative to create the BRICS Vaccine R&D Center was included in the final declaration of the BRICS summit in Johannesburg, South Africa (26-27 July 2018).

The main objective is to share best practices and strengthen practical cooperation in the research, development, production and distribution of vaccines in order to ensure their greater availability. The new format is designed to develop mechanisms for prevention, diagnosis and rapid response to new viruses, as well as to ensure rapid and widespread Covid-19 vaccination.

The launch of the BRICS Vaccine R&D Center is considered a major achievement of the five-party cooperation, in strengthening cooperation in the field of healthcare, in particular through the implementation of the Russian initiative to establish the BRICS integrated early warning system to prevent mass infectious diseases. disease risks under China’s BRICS presidency.

Chinese Foreign Ministry spokesperson Wang Wenbin explained during his regular press conference on March 23 that the BRICS Vaccine R&D Center and Vaccine Cooperation Workshop would be a network of virtual centers based on the Internet, and that the creation of physical centers would only start later after a full feasibility study.

As BRICS chairperson this year, China hosted the 14th BRICS Summit in June under the theme “Fostering High-Quality BRICS Partnership, Ushering in a New Era for Global Development.” Public health and vaccine cooperation are among the key areas of BRICS cooperation. This year. At present, the pandemic is still dragging on across the world.

The establishment of the BRICS Vaccine R&D Center demonstrates the determination of BRICS countries to focus on vaccine cooperation, deepen public health cooperation and build a BRICS line of defense against Covid-19.

“We hope that the vaccine R&D center will pool the strengths of BRICS countries, further promote scientific and technological cooperation among BRICS countries, strengthen the five countries’ ability to prevent and control infectious diseases, contribute to the fight against against Covid-19 and create new contributions to international public health cooperation,” Wang Wenbin said at the press conference.

BRICS countries strive to contribute to enhanced international cooperation to support countries’ efforts to achieve health goals, including the implementation of universal and equitable access to health services, and ensure service delivery. affordable and of good quality while taking into account different national circumstances, policies, priorities and capacities.

The member countries of BRICS (Brazil, Russia, India, China and South Africa) collectively represent approximately 26% of the world’s geographic area and are home to 3.6 billion people, approximately 40% of the world’s population and a gross domestic product ( GDP) nominal combined) of 16.6 trillion US dollars.

Comments are closed.